Informa Markets, producer of the CPhI and Pharmapack Europe exhibitions, has launched Global Pharma Insights, our dedicated platform providing news, features, interviews and in-depth analysis on issues impacting pharmaceutical supply chains. 

The pharmaceutical product lifecycle is a complex process with several touchpoints that needs to balance efficient deployment of essential medicines to patients with strict safety compliance, in one of the world’s most heavily regulated sectors.

The global emergency that is COVID-19 has exerted even more pressure on pharmaceutical supply chains, as the industry races not only to develop potential vaccines and therapies for the virus in record time but also to scale up manufacturing to make these treatments available to a global population.

Each year we unite more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities. Global Pharma Insights provides information to aid effective decision making in all the following sectors and more:

• Drug development (pre-clinical and clinical) • API sourcing and procurement • Drug manufacturing and outsourcing • Pharmaceutical packaging and drug delivery • Pharmaceutical distribution • Cell and gene therapies • Cell and gene therapies • Artificial intelligence and machine learning

Meet at Our Events, Learn at Global Pharma Insights.

Event Related News

Riyadh, Saudi Arabia

CPhI Middle East & Africa to debut in Saudi Arabia in 2021

Abu Dhabi, United Arab Emirates, 8th June 2020: Informa, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, has announced that due to the COVID-19 pandemic, the 2020 edition of the show will no longer take place in Abu Dhabi in September, instead it will now debut in Riyadh, Saudi Arabia in March 2021.

Coronavirus Update

COVID-19 Update

CPhI Middle East & Africa is closely monitoring developments concerning the Coronavirus COVID-19. The health and safety of both our customers and colleagues is always our top priority. As such, we are following all safety advice and precautions as recommended by local Departments of Health, as well as the World Health Organization (WHO).

CPhI Middle East & Africa pharma event completes second successful year in the UAE capital

CPhI Middle East & Africa pharma event completes second successful year in the UAE capital

CPhI Middle East & Africa 2019, the global pharmaceutical showcase held in Abu Dhabi, has concluded after welcoming 234 exhibiting companies and over 3,100 visitors, from 98 countries. His Excellency Sheikh Nahyan bin Mubarak al Nahyan, Minister of Tolerance, opened the event on 16 September, amid the projected US$41 billion the pharmaceutical industry in the MENA region is expected to top by 2022.

Pharma experts discuss the UAE’s commitment to innovation during final day of CPhI, in Abu Dhabi

Pharma experts discuss the UAE’s commitment to innovation during final day of CPhI, in Abu Dhabi

Abu Dhabi, United Arab Emirates, 18 September 2019: CPhI Middle East & Africa concluded today at the Abu Dhabi National Exhibition Centre (ADNEC) with a panel discussion addressing the UAEs commitment to becoming an innovative market while effectively managing healthcare spending in the region.

Saudi Pharma market crucial to country’s Vision 2030, say experts at CPhI in Abu Dhabi

Saudi Pharma market crucial to country’s Vision 2030, say experts at CPhI in Abu Dhabi

CPhI pharma event hosts discussion on how Saudi Arabia pharmaceutical industry is helping to deliver the country’s Vision 2030. The Saudi pharma market is the largest across the MENA region with a market size of US$7.5 billion with a growth expected at a CAGR of around 5.5% according to experts.

HE Sheikh Nahyan bin Mubarak opens pharmaceutical event in Abu Dhabi

HE Sheikh Nahyan bin Mubarak opens pharmaceutical event in Abu Dhabi

His Excellency Sheikh Nahyan bin Mubarak al Nahyan, Minister of Tolerance, inaugurates CPhI Middle East & Africa 2018. Global industry professionals descend upon ADNEC in Abu Dhabi for the region’s leading platform for the pharmaceutical sector.

CPhI Middle East & Africa 2019 opens tomorrow in Abu Dhabi as MENA pharma market set to top US41 billion by 2022

CPhI Middle East & Africa 2019 opens tomorrow in Abu Dhabi as MENA pharma market set to top US41 billion by 2022

The event, which is returning for a second year after its successful launch in the capital last year, will take place at the Abu Dhabi National Exhibition Centre (ADNEC) from 16-18 September 2019. Sponsored by the Ministry of Health and Protection (MoHaP), CPhI is set to attract attendees from the Middle East and Africa (MEA) - of which the MENA region accounts for 4% of the global pharma market - and the rest of the world.

Saudi Arabia’s pharma market to top US$10.74 billion by 2022, says new CPhI MEA report

Saudi Arabia’s pharma market to top US$10.74 billion by 2022, says new CPhI MEA report

Saudi Arabia’s pharmaceutical market expected to grow at a CAGR of 5.5% until 2023. Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.

Dr. Pranay Nikam

Dr Pranay Nikam

PRIDE CHEMTECH DMCC is a pharmaceutical solutions provider with expertise in product development services and raw materials supplies. Ranked as the number one global free zone in 2019 by fDi Magazine, the DMCC Free Zone is the ideal location from which to provide our local and international clients with branded generic dossiers, technology transfers, raw materials supplies and regulatory services.

Mahmoud Farag

Mahmoud Farag

Qualicaps® is a supplier of two-piece hard capsules to the Pharmaceutical and Health & Nutrition industry. Qualicaps® has 5 manufacturing sites globally, with the European headquarters in Madrid, Spain. It is fully owned by Mitsubishi Chemical corporation, Japan.

Cristiano Paganini

Cristiano Paganini

PromoPharma, founded in San Marino in 1998, offers the widest range of effective and safe solutions in the field of Soft Therapies with food supplements, dietary foods for special medical purposes and medical devices.

Mr. Sumit Bhanot

Mr. Sumit Bhanot

Neopharma LLC UAE, is one of the largest pharmaceutical companies in the MENA region with wholly owned subsidiaries in the US, Japan, Brazil, the UK and India. It is a vertically integrated business, comprising of Key Intermediaries, API, R&D and Formulation facilities in regulated and emerging markets.

MENA Pharma Industry Report

MENA Pharma Industry Report

The MENA (Middle East and North Africa) region is a largely untapped, yet potentially hugely fruitful part of the world for the pharmaceutical industry, both as a sales region and for the establishment of manufacturing facilities. Some multinational corporations have already started to invest directly into the region – namely into Saudi Arabia, the most economically powerful country in MENA.